Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Senhwa Enrolls First Patient in Silmitasertib Trial for COVID-19

americanpharmaceuticalreviewDecember 04, 2020

Tag: COVID-19 , Senhwa Biosciences , Silmitasertib , IIT

PharmaSources Customer Service